Login

Dr. Cun-Yu Wang, Academician of the US Institute of Medicine of National Academies, Has Accepted to be CBA’s Scientific Advisor and Lifetime Member

Dr. Cun-Yu Wang, Academician of the US Institute of Medicine of National Academies, Has Accepted to be CBA’s Scientific Advisor and Lifetime Member

 Dear CBA members and friends, 

We have a very exciting news to share with you all!

Dr. Cun-Yu Wang, Member of the Institute of Medicine of National Academies of the United States
, has accepted the invitation to join our organization as a Scientific Advisor to the Board of Directors and as a Lifetime Member.

Dr. Cun-Yu Wang currently is the Associate Dean of Graduate Studies, the Dr. No-Hee Park Endowed Chair in Dentistry, and the Chair of the Division of Oral Biology and Medicine at the UCLA School of Dentistry. Dr. Wang is the first person to hold the Dr. No-Hee Park Endowed Chair in Dentistry.

Dr. Wang is the leading investigator in the field of oral cancer, chronic inflammation, and adult stem cells. He has made a landmark discovery on the regulation of cancer cell death by NF-κB, a transcription factor associated with inflammation and immune responses. His work has been published in the high-impacted journals including Science, Cell, Nature Medicine, Cancer Cell, Nature Cell Biology, Lancet, and Nature Biotechnology. Dr. Wang is among the most highly-cited dentist-scientists at the national and international levels. He was elected to the Institute of Medicine of National Academies (IOM), which is one of the highest honors in medicine and public health in the United States in 2011. He is also the very first Chinese educated medical researcher to receive this type of honor.

CBA is very honored to have Dr. Wang join us at the 2015 Jiangsu (LianYunGang) International Symposium on Bio-Med Innovation and Entrepreneurship & the 20th Annual Conference of CBA, which was just held this June at LianYunGang, Jiangsu Province, China. Dr. Wang’s thought-provoking lecture attributes tremendously to the success of this 20th anniversary event of CBA.

Since its founding 20 years ago, CBA has been serving as a bridge between US and China in the field of medical research with the goal of bringing new pharmaceutical agents to commercial development and healthcare market. Among the many US-based organizations, CBA stands out as the most active, vibrant and engaging one. With Dr. Cun-Yu Wang joining the CBA’s scientific leadership, we believe his wealth of scientific knowledge and experience in both US and Chinese scientific communities would be of a great asset to CBA’s future growth and our continued involvement in translational research and biopharmaceutical development in both countries.

Again, we are very honored and excited to announce Dr. Cun-Yu Wang as a valuable addition to the CBA team. We at CBA look forward to working with the elite scientific leaders like Dr. Wang to take CBA’s mission into the next high level.

Sincerely,
CBA Leadership Team
 

X